Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
PetMed Express
PETS
$41.7M
| $10.8M | ﹤0.01% |
664,939
+80,646
| +14% | +$1.52M |
|
|
TBNK
2202
DELISTED
Territorial Bancorp Inc.
TBNK
| $10.8M | ﹤0.01% |
556,726
-8,622
| -2% | -$197K |
|
2203
Inogen
INGN
$175M
| $10.7M | ﹤0.01% |
859,248
+49,966
| +6% | +$957K |
|
2204
NovoCure
NVCR
$1.73B
| $10.7M | ﹤0.01% |
177,831
+12,948
| +8% | +$1.03M |
|
2205
Limoneira
LMNR
$235M
| $10.6M | ﹤0.01% |
638,302
+19,885
| +3% | +$291K |
|
2206
BioLife Solutions
BLFS
$1.53B
| $10.6M | ﹤0.01% |
488,275
+216,856
| +80% | +$4.88M |
|
2207
Expro Ltd
XPRO
$1.79B
| $10.6M | ﹤0.01% |
577,986
-24,452
| -4% | -$480K |
|
|
CNSL
2208
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $10.6M | ﹤0.01% |
4,104,142
-218,199
| -5% | -$783K |
|
2209
UNIFI
UFI
$119M
| $10.6M | ﹤0.01% |
1,293,270
-47,510
| -4% | -$424K |
|
|
FRGI
2210
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $10.5M | ﹤0.01% |
1,278,323
+31,160
| +2% | +$259K |
|
2211
First Internet Bancorp
INBK
$257M
| $10.5M | ﹤0.01% |
629,645
-27,277
| -4% | -$658K |
|
|
RTL
2212
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $10.4M | ﹤0.01% |
1,661,327
+156,658
| +10% | +$1.02M |
|
2213
Thomson Reuters
TRI
$42.8B
| $10.4M | ﹤0.01% |
76,089
-6,204
| -8% | -$791K |
|
|
OLO
2214
DELISTED
Olo Inc
OLO
| $10.4M | ﹤0.01% |
1,277,318
+633,717
| +98% | +$4.88M |
|
2215
Vaxcyte
PCVX
$7.81B
| $10.4M | ﹤0.01% |
278,043
-6,477
| -2% | -$275K |
|
|
EDR
2216
DELISTED
Endeavor Group Holdings, Inc.
EDR
| $10.4M | ﹤0.01% |
434,651
+67,366
| +18% | +$1.5M |
|
2217
RBB Bancorp
RBB
$448M
| $10.4M | ﹤0.01% |
669,001
+29,699
| +5% | +$568K |
|
|
GOOS
2218
Canada Goose Holdings
GOOS
$872M
| $10.4M | ﹤0.01% |
538,457
-793
| -0.1% | -$15.7K |
|
2219
Southern First Bancshares
SFST
$591M
| $10.4M | ﹤0.01% |
337,520
+20,262
| +6% | +$796K |
|
2220
Haleon
HLN
$43.5B
| $10.4M | ﹤0.01% |
1,272,545
-500,255
| -28% | -$3.99M |
|
|
CBAY
2221
DELISTED
Cymabay Therapeutics
CBAY
| $10.3M | ﹤0.01% |
1,183,236
-131,286
| -10% | -$1.05M |
|
2222
Stantec
STN
$8.04B
| $10.3M | ﹤0.01% |
176,422
-5,196
| -3% | -$281K |
|
|
INN
2223
Summit Hotel Properties
INN
$746M
| $10.2M | ﹤0.01% |
1,464,194
+37,892
| +3% | +$287K |
|
2224
Pitney Bowes
PBI
$2.4B
| $10.2M | ﹤0.01% |
2,632,242
+738,936
| +39% | +$3.1M |
|
2225
Aehr Test Systems
AEHR
$2.61B
| $10.2M | ﹤0.01% |
328,192
+315,009
| +2,390% | +$10.1M |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.